D'après la communication de : Marie-Joelle Kaiser, Pascale Roux-Lombard, Marie-Cecile Bozonnat, Jean-Michel Dayer, Jean-Pierre Daures, Jacques Sany. [Abstract 974] CORRELATION BETWEEN LOW VEGF SERUM LEVELS AND RESPONSIVENESS TO ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS(RA)OR JUVENILE RHEUMATOID ARTHRITIS(JRA). Rapporté par Patrick Chérin, CHU Pitié-Salpétrière, Paris

D'après la communication de : Anca Irinel Catrina, Jon Lampa, Johan Bratt, Sofia Ernestam, Erik av Klint, Lars Klareskog, Ann-Kristin Ulfgren. (Abstract 977) ANTI TUMOR NECROSIS FACTOR (TNF)-a THERAPY (ETANERCEPT) DOWN REGULATES SERUM MATRIX METALLOPROTEINASE (MMP)-3 IN RHEUMATOID ARTHRITIS. Rapporté par Patrick Chérin, CHU Pitié-Salpétrière, Paris

D'après la communication de : Marie-Joelle Kaiser, Phillippe Dieude, Francois Cornelis, Marie-Cecile Bozonnat, Thomas Bardin, Jean-Pierre Daures, Jacques Sany. [Abstract 972] EFFECT OF TNFR2- 196M/R POLYMORPHISM ON THE RESPONSIVENESS TO ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA). Rapporté par Patrick Chérin, CHU Pitié-Salpétrière, Paris

Daprès la communication de : Edward Keystone, Michael Weinblatt, Daniel Furst, Michael Weisman, Larry Moreland, Charles Birbara, Steven Fischkoff, Elliot Chartash. [Abstract 965] THE ARMADA TRIAL: A DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF THE FULLY HUMAN ANTI-TNF MONOCLONAL ANTIBODY, ADALIMUMAB (D2E7), IN PATIENTS WITH ACTIVE RA ON METHOTREXATE (MTX). Rapporté par Patrick Chérin, CHU Pitié-Salpétrière, Paris

Daprès la communication de : Loreto Carmona, Isidoro Gonzalez-Alvaro, Raimon Sanmarti, Balsa Alejandro, Xavier Tena, Miguel Angel Belmonte, Enrique Casado, EMECAR Study Group [Abstract 726] RHEUMATOID ARTHRITIS IS ASSOCIATED TO A FOUR-FOLD INCREASE IN TUBERCULOSIS INFECTION INCIDENCE IN THE PRE-BIOLOGICS ERA Rapporté par Patrick Chérin, CHU Pitié-Salpétrière, Paris

Daprès la communication de : Kristina B Belostocki, Evan Leibowitz, Katy Tai, Melanie J Harrison. (Abstract 725) INFECTIONS ASSOCIATED WITH ETANERCEPT TREATMENT OF RHEUMATOID ARTHRITIS: 2 YEARS OF EXPERIENCE IN THE "REAL-WORLD". Rapporté par Patrick Chérin, CHU Pitié-Salpétrière, Paris

Daprès la communication de : Shepherd Mpofu, A E Maier, Robert J Moots, David Hutchinson. [Abstract 724] SIGMOID DIVERTICULAR ABSCESS PERFORATION IS ASSOCIATED WITH RHEUMATOLOGICAL DISEASE: CORTICOSTEROID THERAPY IS PARTICULARLY IMPORTANT. Rapporté par Patrick Chérin, CHU Pitié-Salpétrière, Paris

Daprès la communication de : Dionicio A Galarza, Jorge A Esquivel-Valerio, Gregorio Navarro, Rebeca Flores-Orta, Cassandra M Skinner, Miguel A Villarreal, Humberto Cavazos-Adame, Mario A Garza-Elizondo. [Abstract 723] PREVALENCE OF CHLAMYDIA OCULAR INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ARE TAKING GLUCOCORTICOIDS. () Rapporté par Patrick Chérin, CHU Pitié-Salpétrière, Paris

D'après la communication de : D L Scott, V Strand, P Emery, J Kremer, M Schiff, L Simon. [Abstract 719] HEMATOLOGICAL AND HEPATIC ADVERSE EVENT PROFILE OF COMMONLY USED DMARDs : EXPERIENCE FROM LEFLUNOMIDE CLINICAL TRIALS. Rapporté par Patrick Chérin, CHU Pitié-Salpétrière, Paris

Daprès la communication de : Rachelle Buchbinder, Anita Wluka, Damien Jolley, Stephen Hall, Andrew Harkness, Daniel Lewis, Geoffrey Littlejohn, Marian Miller, Peter Ryan. [Abstract 717] INCIDENCE OF MALIGNANCY IN A COHORT OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH METHOTREXATE IN COMMUNITY PRACTICE Rapporté par Patrick Chérin, CHU Pitié-Salpétrière, Paris

Daprès la communication de : Adam M Huber, Nina Birdi, Jim King, Peter McLaine, Terry P Klassen, Mary Pothos. [Abstract 710] A RANDOMIZED, PLACEBO CONTROLLED TRIAL OF PREDNISONE IN HENOCH SCHOENLEIN PURPURA. Rapporté par Patrick Chérin, CHU Pitié-Salpétrière, Paris

Daprès la communication de : Takako Miyamae, Tomoyuki Imagawa, Masaaki Mori, Raphael Hirsch, Sumpei Yokota. (Abstract 702) PLASMA EXCHANGE IN KAWASAKI DISEASE REFRACTORY TO HIGH DOSE INTRAVENOUS GANNMAGLOBULIN THERAPY. Rapporté par Patrick Chérin, CHU Pitié-Salpétrière, Paris